Definium Therapeutics, Inc.
Recent Filings
All 437 filings →| Form | Description | Date |
|---|---|---|
| 4 | 4 | Mar 26, 2026 |
| 4 | 4 | Mar 26, 2026 |
| 4 | 4 | Mar 26, 2026 |
| 144 | — | Mar 25, 2026 |
| 144 | — | Mar 25, 2026 |
| 144 | — | Mar 25, 2026 |
| 10-K | 10-K | Feb 26, 2026 |
| 8-K | 8-K | Feb 26, 2026 |
| SCHEDULE 13G/A | — | Feb 17, 2026 |
| SCHEDULE 13G | — | Feb 17, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Karlin Daniel | Chief Medical Officer | Sale | 5,600 @ $13.15 | 425,025 | Dec 26, 2025 |
| Barrow Robert | Chief Executive Officer | Sale | 25,791 @ $13.15 | 778,477 | Dec 26, 2025 |
| Sullivan Mark | Chief Legal Officer | Sale | 11,276 @ $13.15 | 282,576 | Dec 26, 2025 |
| Sullivan Mark | Chief Legal Officer | Sale | 11,278 @ $9.77 | 293,852 | Sep 25, 2025 |
| Barrow Robert | Chief Executive Officer | Sale | 25,797 @ $9.77 | 804,268 | Sep 25, 2025 |
| Karlin Daniel | Chief Medical Officer | Sale | 7,704 @ $9.77 | 430,625 | Sep 25, 2025 |
| Sullivan Mark | Chief Legal Officer | Sale | 11,491 @ $6.80 | 305,130 | Jun 25, 2025 |
| Karlin Daniel | Chief Medical Officer | Sale | 7,848 @ $6.80 | 438,329 | Jun 25, 2025 |
| Barrow Robert | Chief Executive Officer | Sale | 26,491 @ $6.80 | 830,065 | Jun 25, 2025 |
| Barrow Robert | Chief Executive Officer | Sale | 21,208 @ $6.74 | 856,556 | Mar 25, 2025 |